A new DBD update has arrived to improve the ongoing 2v8 Resident Evil event that is taking place through February.

Rapid7 (RPD) came out with quarterly earnings of $0. ... This quarterly report represents an earnings surprise of -4%. A quarter ago, it was expected that this cybersecurity company would post ...

Cybersecurity software maker Rapid7 (NASDAQ:RPD) reported Q4 CY2024 results topping the market’s revenue expectations , with sales up 5.4% year on year to $216.3 million. On the other hand, ...

In trading on Thursday, shares of Rapid7 Inc (Symbol: RPD) entered into oversold territory, hitting an RSI reading of 22.4, after changing hands as low as $33.70 per share. By comparison ...

Rapid7 ended 2024 with $840 million in ARR, in line with our outlook and growing 4% over the prior year ... a full year total of $809 million, while professional services declined 6% as we ...

Rapid7 Inc (NASDAQ:RPD) ended 2024 with $840 million in ARR, growing 4% over the prior year, in line with their outlook. Revenue and operating income exceeded guided ranges, with over $150 million in ...

ROCHESTER, N.Y. — We’re working to learn more about why Rochester Police officers swarmed an area of Mount Read Boulevard on Thursday morning. News10NBC’s photojournalist saw multiple police ...

Cybersecurity software maker Rapid7 (NASDAQ:RPD) reported Q4 CY2024 results topping the market’s revenue expectations , with sales up 5.4% year on year to $216.3 million. On the other hand, next ...

For the quarter ended December 2024, Rapid7 (RPD) reported revenue of $216.26 million, up 5.4% over the same period last year. EPS came in at $0.48, compared to $0.72 in the year-ago quarter.

Corey Thomas, CEO, highlighted Rapid7’s Q4 2024 ARR at $840 million, reflecting 4% growth year-over-year ... revenue grew 6% to $206 million, while professional services declined by 5%.

Building a skin-care routine for teens and tweens can ... into the pores and cleans out the dirt and excess oil.” The 4 percent benzoyl-peroxide concentration in this cleanser is ideal ...

Study Uncovers Potential New Target for Treatment of Chronic, Debilitating Skin Disease Nov. 21, 2024 — Hidradenitis suppurativa (HS) is an immune disease that affects up to 4% of the global ...